市場調查報告書
商品編碼
1471308
人工水晶體市場:按類型、材料和最終用戶分類 - 2024-2030 年全球預測Intraocular Lens Market by Type (Phakic IOLs, Premium IOLs, Traditional/Monofocal IOLs), Material (Foldable IOLs, PMMA IOLs), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年人工水晶體市場規模為42.7億美元,預計2024年將達45.7億美元,2030年將達70.6億美元,複合年成長率為7.44%。
當自然水晶體變得混濁或受損(例如白內障)時,將人工水晶體(人工水晶體)植入眼睛以取代自然水晶體。人工水晶體在眼科領域有廣泛的用途,主要最終用途是白內障患者的矯正手術。由於與老齡化相關的眼科疾病患病率不斷上升,人們對眼保健服務的認知不斷提高,越來越多的人認知到定期眼科檢查的重要性,以及獲得先進治療選擇的機會增加,預計人工水晶體的需求將會增加。然而,人工水晶體植入手術的高成本和風險,如感染、發炎和水晶體脫位,阻礙了市場需求。水晶體材料的創新和設計提高了人工水晶體的功能和性能,使其成為許多情況下視力矯正的首選。已開發國家的患者擴大在國外尋求負擔得起的醫療保健,特別是在以高品質眼部保健服務而聞名的國家,這可能會進一步推動對人工水晶體的需求。
主要市場統計 | |
---|---|
基準年[2023] | 42.7億美元 |
預測年份 [2024] | 45.7億美元 |
預測年份 [2030] | 70.6億美元 |
複合年成長率(%) | 7.44% |
類型患者有水晶體人工水晶體的採用率較高
有水晶體人工水晶體適用於嚴重近視、遠視和散光的患者。這些鏡片旨在與眼睛的天然晶狀體配合使用,而不是取代它。優質人工水晶體具有先進的功能,可解決傳統白內障治療以外的特定視覺狀況。這些鏡片通常可以提供更好的屈光效果,旨在減少手術後對框架眼鏡或隱形眼鏡的依賴。白內障手術後,傳統的或單焦點的人工水晶體聚焦在通常很遠的單點上。這些鏡片是最基本的選擇,術後患者通常需要這些基本眼鏡來執行近距離或中間視力任務。
材質:折疊式人工水晶體切口較小,因此術後恢復較快。
如今,折疊式人工水晶體已成為白內障手術的熱門選擇,因為它們可以透過小切口插入,從而加快癒合速度並縮短恢復時間。這些鏡片主要由柔軟、有彈性的材料製成,例如矽膠、疏水性丙烯酸和親水性丙烯酸。基於需求的折疊式人工水晶體的偏好源於併發症風險的降低、傷口穩定性的改善以及術後患者的舒適度。聚甲基丙烯酸甲酯 (PMMA) 自白內障手術早期就開始使用,因為它具有高生物相容性和光學透明度。當折疊式鏡片停用時(例如對矽樹脂過敏的患者)或考慮成本時,PMMA人工水晶體是首選。
最終用戶:人工水晶體廣泛應用於眼科診所以提供個人化治療。
門診手術中心 (ASC) 是進行門診外科手術的現代化醫療機構,包括白內障手術(包括人工水晶體植入)。這些中心需要為其患者提供高效且經濟高效的人工水晶體。眼科研究所專注於創新研究計劃,為白內障和老花眼等眼科疾病開發尖端解決方案。我們也與產業合作夥伴合作,利用優質材料和技術開發先進的人工水晶體,例如複曲面和多焦點人工水晶體。醫院和診所是人工水晶體植入服務的主要提供者,為不同的患者群體提供服務。需要具有不同特性(例如材料、設計和成本)的人工水晶體來滿足患者的特定需求。眼科診所專注於眼科疾病的治療,通常根據患者的個人需求提供個人化護理。這些診所通常更喜歡優質的人工水晶體還具有其他優點,例如減少眩光和提高對比敏感度。
區域洞察
由於眼部相關疾病的盛行率不斷上升、用於術後視力恢復的人工水晶體技術進步以及微創手術的高消費支出等因素,美洲成為人工水晶體的重要地區。糖尿病患者數量的增加也導致對人工水晶體的需求增加。在歐盟(EU),老年人口增加、眼科疾病率上升、先進醫療基礎設施的可用性以及各種政府措施等因素正在推動人工水晶體市場的成長。在中東和非洲地區,由於人口成長,人們對眼保健服務的認知不斷提高,因此對人工水晶體的需求不斷增加。此外,該地區各國政府正在投資醫療基礎設施開發計劃,其中包括最先進的眼保健設施,從而改善視力矯正手術的機會。由於眼科疾病率不斷上升、醫療基礎設施不斷擴大以及政府對研究舉措的支持,亞太地區成為人工水晶體的重要市場。
FPNV定位矩陣
FPNV定位矩陣對於評估人工水晶體市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對人工水晶體市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,以獲得市場競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.人工水晶體市場規模及預測如何?
2.人工水晶體市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.人工水晶體市場的技術趨勢和法規結構是什麼?
4.人工水晶體市場主要廠商的市場佔有率是多少?
5.進入人工水晶體市場的合適型態和策略手段是什麼?
[199 Pages Report] The Intraocular Lens Market size was estimated at USD 4.27 billion in 2023 and expected to reach USD 4.57 billion in 2024, at a CAGR 7.44% to reach USD 7.06 billion by 2030.
An intraocular lens (IOL) is embedded inside the eye to replace its natural lens when it becomes cloudy or damaged, typically due to cataracts. Intraocular lenses have a wide range of applications in the field of ophthalmology, with the primary end-use being corrective surgery for cataract patients. With a higher prevalence of age-related eye diseases, rising awareness, and accessibility to eye care services as more people become aware of the importance of regular eye check-ups and access to advanced treatment options improve, demand for IOLs is expected to rise. However, high intraocular lens costs and risks associated with IOL implantation surgery, including infection, inflammation, and lens dislocation, hamper its market demand. Innovations in lens material technology and design have improved the functionality and performance of intraocular lenses, making them the preferred option for vision correction in many cases. Patients from developed countries increasingly seek affordable healthcare options abroad, particularly in countries with a reputation for high-quality eye care services, which can further boost the demand for IOLs.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.27 billion |
Estimated Year [2024] | USD 4.57 billion |
Forecast Year [2030] | USD 7.06 billion |
CAGR (%) | 7.44% |
Type: High adoption of phakic intraocular lenses among patients
Phakic intraocular lenses are used for patients with high levels of myopia, hyperopia, or astigmatism. These lenses are designed to work with the eye's natural lens rather than replacing it. Premium intraocular lenses offer advanced features that cater to specific visual conditions beyond traditional cataract treatment. These lenses often provide better refractive outcomes and aim to reduce dependency on eyeglasses or contact lenses post-surgery. Traditional or mono-focal intraocular lenses provide a single focus point at one distance, usually far after cataract surgery. These lenses are the most basic option, and patients typically require these basic eyeglass for near or intermediate vision tasks post-surgery.
Material: Poliferating use of foldable IOLs due to their smaller incision size requirement leading to faster recovery times
Foldable IOLs are a popular choice in modern cataract surgery because they can be inserted through small incisions, leading to faster healing and reduced recovery time. These lenses are primarily made from soft and flexible materials such as silicone, hydrophobic acrylic, and hydrophilic acrylic. The need-based preference for foldable IOLs arises from their reduced risk of complications, better wound stability, and patient comfort during the postoperative period. Polymethyl methacrylate (PMMA) intraocular lenses have been used since the early days of cataract surgery as they offer a high degree of biocompatibility and optical clarity. The need-based preference for PMMA IOLs arises in cases where patients have contraindications to foldable lenses, such as those with silicone allergy, or when cost is a major consideration.
End-User: Extensive use of IOL in ophthalmology clinics to offer personalized care
Ambulatory surgery centers (ASCs) are modern healthcare structures that perform outpatient surgical procedures, including cataract surgery with intraocular lens implantation. These centers require efficient and cost-effective intraocular lenses for their patients. Eye research institutes focus on innovative research projects to develop cutting-edge solutions for eye disorders such as cataracts and presbyopia. They often collaborate with industry partners to develop advanced intraocular lenses with superior materials or technologies, such as toric or multifocal IOLs. Hospitals and clinics are the primary providers of intraocular lens implantation services, catering to a diverse patient population. To meet patients ' specific needs, they require a wide range of intraocular lenses with varying features, such as material, design, and cost. Ophthalmology clinics specialize in treating eye disorders and typically offer personalized care based on individual patient requirements. These clinics often prefer premium intraocular lenses that offer additional benefits such as reduced glare or improved contrast sensitivity beyond standard postoperative visual acuity.
Regional Insights
The Americas has a significant landscape in the intraocular lens owing to factors such as the increasing prevalence of eye-related diseases, technological advancements in IOLs for better visual outcomes post-surgery, and high consumer expenditure on minimally invasive procedures. The rising cases of diabetes also contribute to a higher demand for IOLs. In the European Union, factors such as the growing geriatric population, rising incidences of eye diseases, availability of advanced healthcare infrastructure, and various government initiatives are driving growth in the intraocular lens market. The Middle East and Africa region is noticing a rise in demand for intraocular lenses due to increased awareness about eye health care services among the growing population. Furthermore, governments across this region are investing in healthcare infrastructure development projects incorporating state-of-the-art ophthalmic facilities, resulting in greater accessibility to vision correction surgeries. APAC region constitutes a significant market for intraocular lenses due to the increasing prevalence of eye disorders, expansion of healthcare infrastructure, and government support for research initiatives.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Intraocular Lens Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intraocular Lens Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Intraocular Lens Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC, Aurolab, Bausch Health Companies Inc., Benq Materials Corporation, Care Group Inc., Carl Zeiss AG, Essilor International SAS, EyeKon Medical, Inc., Himalaya Optical, Hoya Corporation, HumanOptics AG, Johnson and Johnson Surgical Vision, Inc., Lenstec Inc., Menicon Co., Ltd., Novartis AG, Omni Lens Pvt. Ltd., Ophtec B.V., PhysIOL S.A., Rayner Intraocular Lenses Limited, SAV IOL S.A., Shanghai Haohai Biological Technology Co. Ltd., and STAAR Surgical Company.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Intraocular Lens Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intraocular Lens Market?
3. What are the technology trends and regulatory frameworks in the Intraocular Lens Market?
4. What is the market share of the leading vendors in the Intraocular Lens Market?
5. Which modes and strategic moves are suitable for entering the Intraocular Lens Market?